{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:34Z","timestamp":1761520114788,"version":"build-2065373602"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41429-025-00859-y","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T10:03:30Z","timestamp":1754561010000},"page":"686-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kaempferol inhibits lipid accumulation in alcoholic fatty liver disease through PRMT-1-mediated arginine methylation of SCD1"],"prefix":"10.1038","volume":"78","author":[{"given":"Jiahui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"859_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","volume":"70","author":"C Lackner","year":"2019","unstructured":"Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019;70:294\u2013304.","journal-title":"J Hepatol"},{"key":"859_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","volume":"18","author":"X Wu","year":"2023","unstructured":"Wu X, Fan X, Miyata T, Kim A, Cajigas-Du RC, Ray S, Huang E, Taiwo M, Arya R, Wu J, Nagy LE. Recent advances in understanding of pathogenesis of alcohol-associated liver disease. Annu Rev Pathol. 2023;18:411\u201338.","journal-title":"Annu Rev Pathol"},{"key":"859_CR3","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41374-020-0439-y","volume":"100","author":"M Huang","year":"2020","unstructured":"Huang M, Kong B, Zhang M, Rizzolo D, Armstrong LE, Schumacher JD, Chow MD, Lee Y, Joseph LB, Stofan M, Zhang L, Guo GL. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency. Lab Investig. 2020;100:1158\u201368.","journal-title":"Lab Investig"},{"key":"859_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Prim. 2018;4:16.","journal-title":"Nat Rev Dis Prim"},{"key":"859_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","volume":"40","author":"L Kong","year":"2021","unstructured":"Kong L, Chen J, Ji X, Qin Q, Yang H, Liu D, Li D, Sun M. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARalpha to activate the NF-kappaB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance. J Exp Clin Cancer Res. 2021;40:18.","journal-title":"J Exp Clin Cancer Res"},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/1874467208666150817112109","volume":"10","author":"M You","year":"2017","unstructured":"You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P. Signal transduction mechanisms of alcoholic fatty liver disease: emerging role of Lipin-1. Curr Mol Pharm. 2017;10:226\u201336.","journal-title":"Curr Mol Pharm"},{"key":"859_CR7","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jconrel.2022.12.041","volume":"353","author":"J Zhao","year":"2023","unstructured":"Zhao J, Ling L, Zhu W, Ying T, Yu T, Sun M, Zhu X, Du Y, Zhang L. M1\/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis. J Controlled Release. 2023;353:1068\u201383.","journal-title":"J Controlled Release"},{"key":"859_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155090","volume":"121","author":"R Wang","year":"2023","unstructured":"Wang R, Deng Z, Zhu Z, Wang J, Yang X, Xu M, Wang X, Tang Q, Zhou Q, Wan X, Wu W, Wang S. Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway. Phytomedicine. 2023;121:155090.","journal-title":"Phytomedicine"},{"key":"859_CR9","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1039\/C5FO00481K","volume":"6","author":"YJ Lee","year":"2015","unstructured":"Lee YJ, Choi HS, Seo MJ, Jeon HJ, Kim KJ, Lee BY. Kaempferol suppresses lipid accumulation by inhibiting early adipogenesis in 3T3-L1 cells and zebrafish. Food Funct. 2015;6:2824\u201333.","journal-title":"Food Funct"},{"key":"859_CR10","doi-asserted-by":"crossref","unstructured":"Tie F, Ding J, Hu N, Dong Q, Chen Z, Wang H. Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells. Int J Mol Sci. 2021;22:8847.","DOI":"10.3390\/ijms22168847"},{"key":"859_CR11","doi-asserted-by":"publisher","first-page":"115113","DOI":"10.1016\/j.biopha.2023.115113","volume":"165","author":"N Li","year":"2023","unstructured":"Li N, Yin L, Shang J, Liang M, Liu Z, Yang H, Qiang G, Du G, Yang X. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway. Biomed Pharmacother. 2023;165:115113.","journal-title":"Biomed Pharmacother"},{"key":"859_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155055","volume":"120","author":"L Xiao","year":"2023","unstructured":"Xiao L, Xu G, Chen S, He Y, Peng F, Yuan C. Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling. Phytomedicine. 2023;120:155055.","journal-title":"Phytomedicine"},{"key":"859_CR13","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1007\/s12035-023-03465-x","volume":"60","author":"K Chang","year":"2023","unstructured":"Chang K, Gao D, Yan J, Lin L, Cui T, Lu S. Critical roles of protein arginine methylation in the central nervous system. Mol Neurobiol. 2023;60:6060\u201391.","journal-title":"Mol Neurobiol"},{"key":"859_CR14","doi-asserted-by":"crossref","unstructured":"Fulton MD, Brown T, Zheng YG. The biological axis of protein arginine methylation and asymmetric dimethylarginine. Int J Mol Sci. 2019;20.:3322.","DOI":"10.3390\/ijms20133322"},{"key":"859_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1369","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiao G, You Y, Li X, Liu J, Sun Z, Li Q, Dai Z, Ma J, Zhou H, Li G, Meng C, Chen Y. Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation. Clin Transl Med. 2023;13:e1369.","journal-title":"Clin Transl Med"},{"key":"859_CR16","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","volume":"81","author":"J Xu","year":"2021","unstructured":"Xu J, Richard S. Cellular pathways influenced by protein arginine methylation: Implications for cancer. Mol Cell. 2021;81:4357\u201368.","journal-title":"Mol Cell"},{"key":"859_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcmgh.2022.09.013","volume":"15","author":"M Schonfeld","year":"2023","unstructured":"Schonfeld M, Villar MT, Artigues A, Weinman SA, Tikhanovich I. Arginine methylation of integrin Alpha-4 prevents fibrosis development in alcohol-associated liver disease. Cell Mol Gastroenterol Hepatol. 2023;15:39\u201359.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"859_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.apsb.2021.09.017","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yu X, Wang Y, Huang Y, Tang J, Gong S, Jiang S, Xia Y, Li F, Yu B, Zhang Y, Kou J. Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling. Acta Pharm Sin B. 2022;12:1198\u2013212.","journal-title":"Acta Pharm Sin B"},{"key":"859_CR19","doi-asserted-by":"publisher","first-page":"3897295","DOI":"10.1155\/2018\/3897295","volume":"2018","author":"M Di Franco","year":"2018","unstructured":"Di Franco M, Lucchino B, Conti F, Valesini G, Spinelli FR, Mirella G, Giovarelli M. Asymmetric dimethyl arginine as a biomarker of atherosclerosis in rheumatoid arthritis. Mediators Inflamm. 2018;2018:3897295\u201313.","journal-title":"Mediators Inflamm"},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cca.2014.11.002","volume":"440","author":"PN Alpoim","year":"2015","unstructured":"Alpoim PN, Sousa LPN, Mota APL, Rios DRA, Dusse LMS. Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease. Clin Chim Acta. 2015;440:36\u201339.","journal-title":"Clin Chim Acta"},{"key":"859_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","volume":"70","author":"M You","year":"2019","unstructured":"You M, Arteel GE. Effect of ethanol on lipid metabolism. J Hepatol. 2019;70:237\u201348.","journal-title":"J Hepatol"},{"key":"859_CR22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.freeradbiomed.2022.10.322","volume":"193","author":"Y You","year":"2022","unstructured":"You Y, Liu C, Liu T, Tian M, Wu N, Yu Z, Zhao F, Qi J, Zhu Q. FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease. Free Radic Biol Med. 2022;193:808\u201319.","journal-title":"Free Radic Biol Med"},{"key":"859_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112304","volume":"42","author":"P Yao","year":"2023","unstructured":"Yao P, Zhang Z, Liu H, Jiang P, Li W, Du W. p53 protects against alcoholic fatty liver disease via ALDH2 inhibition. EMBO J. 2023;42:e112304.","journal-title":"EMBO J"},{"key":"859_CR24","doi-asserted-by":"crossref","unstructured":"Dabeek WM, Marra MV. Dietary Quercetin and Kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients. 2019;11:2288.","DOI":"10.3390\/nu11102288"},{"key":"859_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106005","volume":"175","author":"X Xiao","year":"2022","unstructured":"Xiao X, Hu Q, Deng X, Shi K, Zhang W, Jiang Y, Ma X, Zeng J, Wang X. Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. Pharmacol Res. 2022;175:106005.","journal-title":"Pharmacol Res"},{"key":"859_CR26","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1039\/D1FO00402F","volume":"12","author":"Y Jin","year":"2021","unstructured":"Jin Y, Zhai Z, Jia H, Lai J, Si X, Wu Z. Kaempferol attenuates diquat-induced oxidative damage and apoptosis in intestinal porcine epithelial cells. Food Funct. 2021;12:6889\u201399.","journal-title":"Food Funct"},{"key":"859_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1142\/S0192415X15500160","volume":"43","author":"M Wang","year":"2015","unstructured":"Wang M, Sun J, Jiang Z, Xie W, Zhang X. Hepatoprotective effect of kaempferol against alcoholic liver injury in mice. Am J Chin Med. 2015;43:241\u201354.","journal-title":"Am J Chin Med"},{"key":"859_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","volume":"25","author":"J Jarrold","year":"2019","unstructured":"Jarrold J, Davies CC. PRMTs and arginine methylation: cancer\u2019s best-kept secret? Trends Mol Med. 2019;25:993\u20131009.","journal-title":"Trends Mol Med"},{"key":"859_CR29","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41388-020-01617-0","volume":"40","author":"XK Yin","year":"2021","unstructured":"Yin XK, Wang YL, Wang F, Feng WX, Bai SM, Zhao WW, Feng LL, Wei MB, Qin CL, Wang F, Chen ZL, Yi HJ, Huang Y, Xie PY, Kim T, Wang YN, Hou JW, Li CW, Liu Q, Fan XJ, Hung MC, Wan XB. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer. Oncogene. 2021;40:1375\u201389.","journal-title":"Oncogene"},{"key":"859_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-022-02500-4","volume":"41","author":"S Liu","year":"2022","unstructured":"Liu S, Liu Z, Piao C, Zhang Z, Kong C, Yin L, Liu X. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer. J Exp Clin Cancer Res. 2022;41:1\u2013293.","journal-title":"J Exp Clin Cancer Res"},{"key":"859_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/01.RES.87.2.99","volume":"87","author":"RH Boger","year":"2000","unstructured":"Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D. Bode-Boger SM. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res. 2000;87:99\u2013105.","journal-title":"Circ Res"},{"key":"859_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2337\/db13-1394","volume":"64","author":"D Kim","year":"2015","unstructured":"Kim D, Park M, Lim S, Park J, Yoon K, Han H, Gustafsson J, Lim J, Park S. PRMT3 regulates hepatic lipogenesis through direct interaction with LXR\u03b1. Diabetes. 2015;64:60\u201371.","journal-title":"Diabetes"},{"key":"859_CR33","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","volume":"30","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cai J, Yang X, Wang K, Sun K, Yang Z, Zhang L, Yang L, Gu C, Huang X, Wang Z, Zhu X. Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Mol Ther. 2022;30:2342\u201353.","journal-title":"Mol Ther"},{"key":"859_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01297-9","volume":"21","author":"W Wang","year":"2023","unstructured":"Wang W, Kong Y, Wang X, Wang Z, Tang C, Li J, Yang Q, Chen YQ, Zhu S. Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis. Cell Commun Signal. 2023;21:268.","journal-title":"Cell Commun Signal"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00859-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00859-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:03:07Z","timestamp":1761519787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00859-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00859-y","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"type":"print","value":"0021-8820"},{"type":"electronic","value":"1881-1469"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}